Company intelligence / Profile preview

Corticale

Genova, Liguria, Italy

Ownership: Private
Development stage: Other

Overview

Corticale has developed ultra-high density minimally invasive neural implants using CMOS technology, designed for high-resolution long-term interaction with thousands of neurons simultaneously; clinical testing or human studies are not mentioned.

Therapeutic areas: OtherNeurology
Modalities: Device (Neural implant)
Industry: Implantable Medical Devices

Partnerships

Supported by grants from Liguria Region PR FESR program (public funding, not corporate pharma/biotech partners)

Beyond the preview

Go deeper on Corticale.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Corticale.

Explore the full profile